Ukrainian Journal of Perinatology and Pediatrics. 2021.2(86): 57-67; doi 10.15574/PP.2021.86.57
Mochulska O. M.
I. Horbachevsky Ternopil National Medical University, Ukraine

For citation: Mochulska OM. (2021). Features of pathogenesis of itch and anti-itch therapy in children with allergic dermatosis (literature review). Ukrainian Journal of Perinatology and Pediatrics. 2(86): 57-67. doi 10.15574/PP.2021.86.57
Article received: Feb 24, 2021. Accepted for publication: Jun 15, 2021.

Allergic dermatoses are allergic skin diseases, the most common of which are: simple and allergic contact dermatitis, atopic dermatitis, various forms of eczema, acute and chronic allergic urticaria, Quincke's edema, toxicodermias, multiforme exudative erythema (Stevens–Johnson syndrome), acute epidermal necrolysis (Lyell's syndrome). The clinical course of all allergic dermatoses is accompanied by itch, although its severity varies depending on the nosology. An important focus of treatment of allergic dermatoses is to control of skin itch, as it is the leading symptom. According to the international program documents EAACI (European Academy of Allergy and Clinical Immunology), AAAAI (American Academy of Allergy, Asthma & Immunology), PRACТALL (Practical Allergology Consensus Report) in treatment of allergic dermatoses the leading place takes anti-itch therapy, which requires an individual approach and daily care of skin. Systemic anti-itch therapy includes using of the following drugs: antihistamines, glucocorticosteroids, membrane's stabilizators (kromons), leukotriene receptor antagonists, anti-IgE. External anti-itch therapy consists of local application of emollients, topical glucocorticosteroids, topical calcineurin inhibitors, topical anti-histamines, reparants and epithelializing medications.
Purpose — to increase knowledge about features of etiopathogenetically-based anti-itch therapy of allergic dermatoses in children.
Conclusions. Treatment of itch of allergic dermatoses is diverse, complex and multi-stage, requires an individual approach to each patient, and includes: environmental control to eliminate allergenic and non-allergenic factors, systemic and local pharmacotherapy, skin care. Modern anti-itch therapy of allergic dermatoses should be etiopathogenetic and affect on local and system mechanisms of allergic inflammation with itch, it should be differentiated according to the stage of the disease, the phase of inflammation and the severity of skin manifestations and to be based on the rational use of drugs.
No conflict of interest was declared by the author.
Key words: children, allergy, allergic dermatoses, itch, anti-itch therapy.

REFERENСES

1. Beltrani VS. (1998). Allergic Dermatoses. Medical Clinics of North America. 82 (5): 1105-1133. URL: http://www.sciencedirect.com/science/article/pii/S0025712505704053. https://doi.org/10.1016/S0025-7125(05)70405-3

2. Dowling PJ, Kader R, Portnoy JM. (2019). COLA (Conferences On-Line Allergy) at 10 Years – Evolution of an Online Fellowship Curriculum. The Journal of Allergy and Clinical Immunology: In Practice. 7 (8): 2568-2573. URL: http://www.sciencedirect.com/science/article/pii/S2213219819305975. https://doi.org/10.1016/j.jaip.2019.06.025; PMid:31279862

3. Erickson S, Heul AV, Kim BS. (2021). New and emerging treatments for inflammatory itch. Annals of Allergy, Asthma & Immunology. 126 (1):13-20. URL: http://www.sciencedirect.com/science/article/pii/S1081120620303914. https://doi.org/10.1016/j.anai.2020.05.028; PMid:32497711

4. Fowler E, Yosipovitch G. (2019). Chronic itch management: therapies beyond those targeting the immune system. Annals of Allergy, Asthma & Immunology. 123 (2): 158-165. URL: http://www.sciencedirect.com/science/article/pii/S1081120619300857. https://doi.org/10.1016/j.anai.2019.01.016; PMid:30685562

5. Golpanian RS, Gonzalez JM, Yosipovitch G. (2020). Practical Approach for the Diagnosis and Treatment of Chronic Pruritus. The Journal for Nurse Practitioners. 16 (8): 590-596. URL: http://www.sciencedirect.com/science/article/pii/S1555415520302531. https://doi.org/10.1016/j.nurpra.2020.05.002

6. Katayama I, Izuhara K. (2017). Itch: Its perception and involvement in allergy. Allergology International. 66 (1): 1-2. URL: http://www.sciencedirect.com/science/article/pii/S132389301630168X. https://doi.org/10.1016/j.alit.2016.11.004; PMid:28081841

7. Lee C-H. (2016). Immune regulation in pathophysiology and targeted therapy for itch in atopic dermatitis. Dermatologica Sinica. 34 (1): 1-5. URL: http://www.sciencedirect.com/science/article/pii/S1027811715001123. https://doi.org/10.1016/j.dsi.2015.10.002

8. Leung DY. (2019). Cutaneous allergy: control that itch-scratch cycle. Annals of Allergy, Asthma & Immunology. 123 (2): 115. URL: http://www.sciencedirect.com/science/article/pii/S1081120619303928. https://doi.org/10.1016/j.anai.2019.05.016; PMid:31376840

9. Nguyen V, Simon L, Jaqua E. (2016). Allergic Dermatoses. Primary Care: Clinics in Office Practice. 43 (3): 433-449. URL: http://www.sciencedirect.com/science/article/pii/S0095454316300239. https://doi.org/10.1016/j.pop.2016.04.011; PMid:27545733

10. Rees J. (2005). Itch: basic mechanisms and therapy. Journal of the American Academy of Dermatology. 52 (3): 543-544. URL: http://www.sciencedirect.com/science/article/pii/S019096220403745. https://doi.org/10.1016/j.jaad.2004.09.045

11. Yang TL, Kim BS. (2019). Pruritus in allergy and immunology. Journal of Allergy and Clinical Immunology. 144 (2): 353-360. URL: http://www.sciencedirect.com/science/article/pii/S0091674919308280. https://doi.org/10.1016/j.jaci.2019.06.016; PMid:31395149 PMCid:PMC6690370

12. Yosipovitch G, Rosen Jordan Danie, Hashimoto T. (2018). Itch: From mechanism to (novel) therapeutic approaches. Journal of Allergy and Clinical Immunology. 142 (5): 1375-1390. URL: http://www.sciencedirect.com/science/article/pii/S0091674918313526. https://doi.org/10.1016/j.jaci.2018.09.005; PMid:30409247